Daniel Wolfe

Daniel Wolfe

Direttore/Membro del Consiglio presso PARABELLUM ACQUISITION CORP.
49 anni
Finance
Health Technology
Electronic Technology

Profilo

Daniel B. Wolfe is President, Chief Executive Officer & Director at Synglyco, Inc. Dr. Wolfe is Managing Director at BC Partners, Inc. starting in 2025.
Dr. Wolfe is Director at Phoenix Molecular Corp.
Dr. Wolfe is Director at Prosep USA, Inc. Dr. Wolfe is Director at Parabellum Acquisition Corp.
since 2021.
Dr. Wolfe is Vice President at Continental Stock Transfer & Trust Co. Dr. Wolfe is President & Chief Operating Officer at Harris & Harris Enterprises, Inc. since 2009.
Dr. Wolfe is President, Chief Financial & Compliance Officer at 180 Degree Capital since 2017.
Former roles include President, Chief Financial Officer & Director at 180 Degree Capital Corp.
from 2017 to 2025.
Dr. Wolfe was Director at Evolved Nanomaterial Sciences, Inc., SiOnyx LLC, Laird Durham, Inc., Laser Light Engines, Inc., Produced Water Absorbents, Inc., and Ultora, Inc. Dr. Wolfe was Director at Enumeral Biomedical Holdings, Inc. from 2014 to 2015.
Dr. Wolfe was Director & Secretary at Enumeral Biomedical Corp.
in 2011.
Dr. Wolfe was President, CFO & Chief Compliance Officer at 180 Degree Capital Corp.
(Investment Management) from 2016 to 2025.
Dr. Wolfe was President at Scientific Venture Assessments, Inc. from 2000 to 2002.
Education includes a doctorate and graduate degree from Harvard University and an undergraduate degree from William Marsh Rice University conferred in 1999.

Posizioni attive di Daniel Wolfe

SocietàPosizioneInizio
PARABELLUM ACQUISITION CORP. Direttore/Membro del Consiglio 27/09/2021
Direttore Finanziario/CFO 01/07/2016
Corporate Officer/Principal -
Direttore/Membro del Consiglio -
Amministratore Delegato -
Harris & Harris Enterprises, Inc.
Presidente 01/01/2009
Phoenix Molecular Corp.
Direttore/Membro del Consiglio -
Investitore di Private Equity 01/09/2025

Precedenti posizioni note di Daniel Wolfe

SocietàPosizioneFine
180 DEGREE CAPITAL Direttore Finanziario/CFO 02/09/2025
░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di Daniel Wolfe

Formazione di Daniel Wolfe

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

69

Relazioni di 1° grado

21

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private21

Miscellaneous

Finance

Health Technology

Electronic Technology

Electronic Technology

Health Technology

Producer Manufacturing

Harris & Harris Enterprises, Inc.

Health Technology

Consumer Services

Consumer Services

Miscellaneous

Phoenix Molecular Corp.

Scientific Venture Assessments, Inc.

Commercial Services

Industrial Services

Finance

Electronic Technology

Industrial Services

Finance

Finance

  1. Mercati
  2. Insiders
  3. Daniel Wolfe